Maravai LifeSciences Holdings, Inc. (MRVI) Gross margin 2019–2025
Maravai LifeSciences Holdings, Inc. (MRVI) gross margin by fiscal year — reported gross profit divided by reported revenue.
18.3%FY2025 · since FY2019: 53.3% → 18.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 18.3% | -23.5 pp |
| FY2024 | 41.8% | -6.7 pp |
| FY2023 | 48.5% | -32.3 pp |
| FY2022 | 80.9% | -1.5 pp |
| FY2021 | 82.4% | +10.4 pp |
| FY2020 | 72.0% | +18.7 pp |
| FY2019 | 53.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice